What's breaking now, across thousands of outlets.
(MedPage Today) -- Recent studies suggest that people with type 2 diabetes on GLP-1 receptor agonists were less likely to develop tuberculosis (TB) or be hospitalized or die from infections. In an international study of more than 7 million people...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The CDC has tallied nearly 30,000 confirmed and probable cases this summer.
As part of efforts to contain the diphtheria outbreak in Katsina, the government says it has vaccinated 150,346 people within five days The Chief Press Secretary to the Katsina State Governor, Ibrahim…
The president was asked about Democratic candidates who want to use Medicare to provide universal access to health care — and he said his approach to have confidential drug pricing deals was superior.
A 76-year-old man with prostate cancer has been detained by immigration officials for more than two months, relatives said.
(MedPage Today) -- Use of GLP-1 receptor agonists was associated with increased cumulative gallbladder and biliary events in youths, according to a retrospective analysis of TriNetX data.
Side effects observed in testing have led Novartis to halt development of rap-cel in multiple indications and Bristol Myers to voluntarily pause its zola-cel program.
